Skip to main content
Lung CancerDiagnostics and screeningDigital health

What this study is

The goal of this clinical trial is to evaluate whether an AI tool that alerts providers to patients at high 6-year risk of lung cancer based on their chest x-ray images will improve lung cancer screening CT participation. The main question it aims to answer is: Does the AI tool improve lung cancer screening CT participation at 6 months after the baseline outpatient visit?

The intervention is an alert to the provider to discuss lung cancer screening CT eligibility, for patients considered at high risk of lung cancer based on CXR-LC AI tool. Intervention and non-intervention arms will be compared to determine if lung cancer screening CT participation increases.

Individuals who are considered high-risk by the tool, but who do not meet the Medicare/USPSTF pack-year or quit-date lung screening eligibility criteria may be offered research lung screening CT.

What's being tested

  • CXR-LC

    Intervention · OTHER

    Alert to provider to discuss lung cancer screening CT eligibility, for patients considered at high risk of lung cancer based on CXR-LC AI tool.

Study details

Official title
Deep Learning Using Routine Chest X-Rays and Electronic Medical Record Data to Identify High Risk Patients for Lung Cancer Screening CT
Sponsor
Massachusetts General Hospital
Conditions
Lung Cancer · Health Screening · Early Cancer Detection · Deep Learning
Enrolling
1,500 people
Starts
2025-05-20
Est. completion
2027-07-01
Design
Double-blind, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗